EYE

ADVANCED MEDICAL OPTICS INC

8 superinvestors own EYE

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
David Einhorn	Greenlight Capital	6.21%	2,809,100	$68.5M	2004Q1	Reduced
ValueAct Capital	ValueAct Capital	4.51%	8,811,635	$178.9M	2008Q1	Held
Henry Ellenbogen	Durable Capital Partners	1.24%	3,073,624	$119.1M	2022Q4	Held
Meridian / ArrowMark	Meridian Contrarian Fund	0.38%	2,404,061	$31.5M	2024Q2	Reduced
Viking Global Investors	Viking Global Investors	0.16%	121,000	$5.1M	2005Q4	Reduced
Kenneth Fisher	Fisher Asset Management	0.01%	670,143	$16.3M	2023Q2	Reduced
Bill Nygren	Oakmark Select Fund – Harris Associates	0.01%	10,000	$197K	2003Q4	Held
First Eagle Investment Management	First Eagle Investment Management	0.01%	221,552	$5.7M	2026Q1	Reduced

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind EYE activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.